Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- VECO +27.3%, KIDS +10%, KBH +9.7%, QTRX +9.7%, INGN +9.4%, TGTX +4.8%, MMSI +3.5%, DHR +1.3%
Other news:
- HEES +106.6% (H&E Equipment to be acquired by United Rentals (URI) for $92/share in cash)
- RILY +13.7% (Files 10-Q for Quarter Ended June 30)
- APLD +12.4% (forms partnership with Macquarie Asset Management for funding of up to $5.0 billion)
- ANGI +9.6% (approves plan to spin off full stake in Angi)
- ZENV +9.2% (new strategic cycle)
- RGNX +8.8% (forms exclusive partnership with Nippon Shinyaku to develop and commercialize RGX-121 and RGX-111)
- TIL +8% (announces clinical progress in China for IMM2510/SYN-2510, a clinical-stage PD-L1xVEGF bispecific antibody)
- NVA +6.7% (issued 35,007,644 ordinary shares of the Company to Nebari Gold Fund 1 upon conversion of US$5,420,934 in principal under the Nebari convertible loan facility)
- AMRC +6.6% (awarded $183 U.S. General Services Administration project)
- DRS +4.6% (awarded $99 mln U.S. Army contract)
- WNC +4.1% (announces executive leadership changes)
- TDOC +3.6% (enters Amazon's (AMZN) Health Benefits Connector for cardiometabolic programs)
- HCM +3.4% (receives NMPA full approval for ORPATHYS in China)
- URI +3.3% (H&E Equipment to be acquired by United Rentals (URI) for $92/share in cash)
- INSG +2.9% (inclusion in T-Mobile Partner Plus program)
- CCCC +2.6% (announces 2025 milestones across clinical portfolio of degrader medicines pursuing targets of high unmet need in oncology)
- SANW +2.4% (to explore and evaluate strategic alternatives)
- HHH +2.4% (confirms receipt of unsolicited acquisition proposal from Pershing Square)
- GBCI +2% (acquisition of Bank of Idaho Holding)
- IVZ +1.9% (AUM for December)
- BNTX +1.9% (provides business and pipeline updates at 43rd Annual J.P. Morgan Healthcare Conference)
- NATL +1.7% (announces Chief Financial Officer transition)
- ICFI +1.6% (awarded $40 mln U.S. Department of Homeland Security contract)
- MDT +1.4% (CMS national coverage analysis for Symplicity Spyral Renal Denervation System)
- AESI +1.2% (first commercial delivery of sand off the Dune Express)
- SLDP +1.2% (COO to resign)
- GRAL +1% (Patient Reported Outcomes for GRAIL's Galleri Multi-Cancer Early Detection Blood Test Published in Lancet Oncology)
- OCUL +1% (shares SOL-R enrollment progress and next steps for AXPAXLI in NPDR)